COVID Vaccinations Less Prevalent in Marginalized Patients COVID Vaccinations Less Prevalent in Marginalized Patients
Primary care doctors who serve marginalized communities had the highest rate of patients unvaccinated against COVID-19 in a recent study.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 15, 2024 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Extension Data Reported for Chronic Hand Eczema Treatment Extension Data Reported for Chronic Hand Eczema Treatment
Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 12, 2024 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Topical Vs Oral Minoxidil for AGA: Which Is More Effective? Topical Vs Oral Minoxidil for AGA: Which Is More Effective?
Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 12, 2024 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Vaccine'Will Not Curb' Dengue Epidemic, Says PAHO Vaccine'Will Not Curb' Dengue Epidemic, Says PAHO
The vaccine should be used alongside measures such as vector control, prevention, and education, according to the organization.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 12, 2024 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
FDA Expands Benralizumab Use for Asthma to Kids Over Age 6 FDA Expands Benralizumab Use for Asthma to Kids Over Age 6
The maintenance treatment for severe asthma with an eosinophilic phenotype originally was approved for patients aged 12 years and older.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 11, 2024 Category: Allergy & Immunology Tags: Pediatrics News Alert Source Type: news
Tocilizumab Withdrawal Post Remission in Still's Disease Tocilizumab Withdrawal Post Remission in Still's Disease
Longer tocilizumab administration intervals and lower prednisolone doses seemed pivotal for successful tocilizumab withdrawal while maintaining remission in patients with AOSD.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 11, 2024 Category: Allergy & Immunology Tags: Rheumatology Clinical Summary Source Type: news
Childhood Atopic Dermatitis Linked to IBD Risk Childhood Atopic Dermatitis Linked to IBD Risk
A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 10, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
FDA OKs First CAR T-cell Trial for Children With Lupus FDA OKs First CAR T-cell Trial for Children With Lupus
The trial is expected to begin this summer and will enroll 12 individuals under age 18 years.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 10, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Pfizer RSV Shot Meets Goals in Trial Of High-risk Adults Under Age 60 Pfizer RSV Shot Meets Goals in Trial Of High-risk Adults Under Age 60
Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 9, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Hepatitis E Vaccine Shows Long-Term Efficacy Hepatitis E Vaccine Shows Long-Term Efficacy
While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 8, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 7, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news
Bone Infections Increase After S aureus Bacteremia in RA Bone Infections Increase After S aureus Bacteremia in RA
The use of orthopedic implants or tumor necrosis factor inhibitors doubled the risk for bone infections in patients with RA who had contracted S aureus bacteremia.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 5, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
AstraZeneca's Imfinzi Improves Survival in Late-stage Lung Cancer Trial AstraZeneca's Imfinzi Improves Survival in Late-stage Lung Cancer Trial
AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 5, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news
S2 Episode 4: RSV Prevention and Transmission in Healthcare Facilities S2 Episode 4: RSV Prevention and Transmission in Healthcare Facilities
Join Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 3, 2024 Category: Allergy & Immunology Tags: Infectious Diseases InDiscussion Source Type: news
Twice-Daily PPI Leads to Higher EoE Remission Rates Twice-Daily PPI Leads to Higher EoE Remission Rates
The most optimal proton pump inhibitor regimen for histologic response in EoE may be a twice-daily moderate dose, with no additional benefits of a higher dose.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Gastroenterology Source Type: news
